NutraCore Health Products

CLOSEOUT LETTER NutraCore Health Products MARCS-CMS 542906 — September 11, 2018 More Warning Letters Warning Letters About Warning and Close-Out Letters Product: Drugs Recipient: Recipient Name Mr. Chris Beekman NutraCore Health Products Nutracore Health Products 1207 Halapa Way Trinity , FL 34638 United States Issuing Office: DEPARTMENT OF HEALTH AND HUMAN SERVICES FOOD AND DRUG ADMINISTRATION SILVER SPRING , MD 20993 United States Dear Mr. Beekman: The Food and Drug Administration (FDA) has completed an evaluation of your firm's corrective actions in response to our Warning Letter # 542906, issued January 11, 2018. Based on our evaluation, it appears you have addressed the violations contained in the Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Carrie Lawlor Branch Chief Dietary Supplement and Labeling Assessment  Branch Division of Enforcement Office of Compliance Center for Food Safety and Applied Nutrition Content current as of: 10/15/2018 Regulated Product(s) Drugs